• About Us
  • AKIP
  • Live TV
  • Our Programs
  • Latest News
    • Church News
    • Politics
    • Foreign News
    • Security
  • Airtime
  • From GM’s Desk
  • Church of Nigeria
  • Contact
Facebook Twitter Instagram
  • AKIP
  • From GM’s Desk
  • Live TV
Facebook Twitter Instagram
Advent Cable Network Nigeria Advent Cable Network Nigeria
  • Home
  • About Us
  • AKIP
  • Latest News
    • Church News
    • Politics
    • Security
    • Foreign News
    • Sport
  • Live TV
  • Our Programs
  • Airtime
  • Church of Nigeria
  • Contact
Donate
Advent Cable Network Nigeria Advent Cable Network Nigeria
Home»Foreign News»Trial drug in U.S. offers hope for patients
Foreign News

Trial drug in U.S. offers hope for patients

ACNN TVBy ACNN TVApril 30, 2020No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp
Share
Facebook Twitter LinkedIn Pinterest Email WhatsApp

PATIENTS with advanced COVID-19 who received the experimental drug remdesivir recovered faster than similar patients who received placebo, according to preliminary trial data, the National Institute of Allergy and Infectious Diseases said on Wednesday.

“The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery,” the institute’s director, Dr. Anthony Fauci, told CNN.
About 1,090 people participated in the trial internationally, Fauci said, calling it “the first truly high-powered randomised placebo-controlled trial.”

Preliminary data show remdesivir has improved recovery time for coronavirus patients from 15 to 11 days.

“Although a 31% improvement doesn’t seem like a knockout 100%, it is a very important proof of concept,” Fauci said, “because what it has proven is that a drug can block this virus.”

He said the results are “opening the door to the fact that we now have the capability of treating” coronavirus.

Fauci also said the US Food and Drug Administration is working with Gilead Sciences, the maker of remdesivir, to make the drug available to those who need it.

The FDA has not yet approved any drugs for the treatment of the coronavirus but is trying to increase the availability of remdesivir.

“As part of the FDA’s commitment to expediting the development and availability of potential COVID-19 treatments, the agency has been engaged in sustained and ongoing discussions with Gilead Sciences regarding making remdesivir available to patients as quickly as possible, as appropriate,” FDA spokesman Michael Felberbaum said in a statement.

The World Health Organization said it’s too early to comment on the remdesivir trial results released yesterday.

“Typically, you don’t have one study that will come out that will be a game-changer,” said Dr Maria Van Kerkhove, the WHO’s technical lead for the coronavirus response.

She said the agency generally pulls together evidence from several studies before reviewing and critiquing the evidence.

“It can sometimes take a number of publications to determine (what) the ultimate impact of a drug is,” said Dr Mike Ryan, executive director of the WHO’s health emergencies program.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp

Related Posts

Deborah: Can, Plateau, Benue Churches Adamant, Insist On Sunday Protest

May 18, 2022

Nigeria, Uganda And Rwanda Provinces Response To Issues Surrounding 2022 Lambeth Conference And Anglican Communion

May 6, 2022

Nazir-Ali back in an Anglican pulpit

May 4, 2022
Add A Comment

Leave A Reply Cancel Reply

Recent Posts

US House Speaker Pelosi Ban From Receiving Holy Communion

May 23, 2022

My Wedding Testimony By Bishop Obi Of Nnewi Diocese

May 20, 2022

Archbishop of Canterbury, Justin Welby condemns killing of Deborah Samuel

May 19, 2022

Bishop Ebirien Bows Out As Bishop Of Niger Delta As He Clocks 70

May 18, 2022

HAVING A FAITHFUL AND FRUITFUL ANGLICAN MINISTRY UNDER GOD

May 18, 2022
Advent Cable Network Nigeria

ACNNTV is the Televangelism arm of the Church of Nigeria (Anglican Communion) with focus to keep the orthodox faith alive through development of inspiring and life changing broadcast products.

Facebook Twitter Instagram
Quick Links
  • About Us
  • AKIP
  • Board of Management
  • Contact
  • Privacy Policy
Quick Links
  • Our Programs
  • Program Rates
  • From GM’s Desk
  • Live TV

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2022 Anglican Cable Network Nigeria,Abuja. Designed by Dominion Web.

Type above and press Enter to search. Press Esc to cancel.